menu
    • menu

    Company profile for Niagen Bioscience

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Niagen BioscienceFlag
    Country
    Country
    --
    Address
    Address
    --
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    --
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Niagen Bioscience Acquires Full Ownership Of Vital NAD+ Patents
    Niagen Bioscience Acquires Full Ownership Of Vital NAD+ Patents

    24 Dec 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/niagen-bioscience-secures-full-ownership-of-key-nad-patents-in-major-ip-move-18667

    INDPHARMAPOST
    24 Dec 2025
    Share Share
    Niagen Bio Acquires Patent Portfolio From Queen's University
    Niagen Bio Acquires Patent Portfolio From Queen's University

    22 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-22/niagen-bioscience-acquires-existing-core-nicotinamide-riboside-nr-patent-portfolio-from-queen-s-un

    PHARMIWEB
    22 Dec 2025
    Share Share
    Niagen Bioscience Introduces Tru Niagen Beauty
    Niagen Bioscience Introduces Tru Niagen Beauty

    13 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251113779285/en/Niagen-Bioscience-Launches-Tru-Niagen-Beauty-The-First-NAD-Skincare-Supplement-in-the-U.S.-Featuring-Niagen-Patented-Nicotinamide-Riboside

    BUSINESSWIRE
    13 Nov 2025
    Share Share
    Niagen Bioscience Unveils Long COVID Trial Results
    Niagen Bioscience Unveils Long COVID Trial Results

    12 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251112992378/en/Niagen-Bioscience-Announces-Results-from-First-Ever-Randomized-Controlled-Trial-Exploring-Niagen-Patented-Nicotinamide-Riboside-NR-Supplementation-in-Long-COVID

    BUSINESSWIRE
    12 Nov 2025
    Share Share
    Niagen Bioscience Announces $10 Million Share Repurchase Program
    Niagen Bioscience Announces $10 Million Share Repurchase Program

    06 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251106627464/en/Niagen-Bioscience-Announces-%2410-Million-Share-Repurchase-Program

    BUSINESSWIRE
    06 Nov 2025
    Share Share
    Niagen Bioscience Reports Q3 2025 Financial Results
    Niagen Bioscience Reports Q3 2025 Financial Results

    04 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251104318037/en/Niagen-Bioscience-Inc.-Reports-Third-Quarter-2025-Financial-Results-and-Reaffirms-Increased-Full-Year-Outlook

    BUSINESSWIRE
    04 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Contact Niagen Bioscience and get a quotation

    Niagen Bioscience is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Paclitaxel bulk offered by Niagen Bioscience

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search